PopVax CEO on personalised cancer vaccines: ‘Experimental option, not established cure’
Firstpost

The Hyderabad-based startup’s new RNA Foundry will design custom tumour-
targeting vaccines, but the tech remains strictly experimental. Founder and
CEO Soham Sankaran explains how the process works and talks about the future
of oncology care





